Our recent research on the "Blood Collection Devices Market Forecast to 2030 ? Global Analysis ? Product, Method, and End User" indicates that the blood collection devices market was valued at approximately US$ 8,713.21 million in 2022 and is projected to grow to around US$ 14,021.79 million by 2030. This growth represents an estimated compound annual growth rate (CAGR) of 6.1% from 2020 to 2030.
Blood collection devices are essential for the safe extraction of blood. Blood samples are taken from donors for a variety of diagnostic tests. Various tools, including needles, syringes, and lancets, are utilized for both arterial and venous blood collection. Arterial blood collection offers several benefits, such as the ability to sample arterial blood gases and facilitate intraoperative blood salvage. However, collecting blood from patients with difficult venous access (DVA) presents significant challenges. Traditional blood collection devices often struggle to obtain sufficient samples from these patients, leading to multiple attempts that can increase the risk of anemia and the potential transmission of blood-borne pathogens to healthcare workers. To address these issues, companies have developed innovative hematology-tube designs that enable capillary blood collection, minimizing the risks associated with blood collection and treatment errors in DVA patients. This new technology provides a painless, needle-free, and user-friendly method for obtaining blood samples, utilizing a minimally invasive approach. When applied to a patient?s upper arm, the hematology tube enhances capillary blood flow through micro-incisions and patented skin vasodilation techniques.
In May 2022, Vitestro, a Dutch company specializing in medical robotics, unveiled the most advanced autonomous blood drawing device at the annual meeting of the Netherlands Society for Clinical Chemistry and Laboratory Medicine (NVKC) in Rotterdam. This device integrates AI-driven, ultrasound-guided 3D reconstruction with robotic needle insertion, ensuring precise and secure blood collection.
Additionally, in February 2022, Abacus dx introduced the RNA Complete BCT, the latest addition to Streck?s established blood collection tube range. This innovative tube preserves cell-free RNA concentration during draw time while minimizing the release of extracellular vesicles, such as exosomes, from blood cells. These advancements are expected to shape future trends in the blood collection devices market.
Insights on Blood Collection Devices Market by Product
The blood collection devices market is categorized by product into blood collection tubes, blood collection needles/holders, blood collection sets, and other devices. The blood collection tube segment is further divided into evacuated blood collection tubes and micro-collection tubes. In 2022, blood collection tubes accounted for the largest market share and are anticipated to exhibit the highest CAGR from 2022 to 2030. These tubes serve as specimen-collecting containers designed to gather the required volume of blood samples. They are pre-sterilized and equipped with closure caps, and come in various types based on their contents, including anticoagulants, stabilizers, enzymes, and other reagents.
Insights on Blood Collection Devices Market by Method
The market is also segmented by method into manual blood collection and automated blood collection. In 2022, the manual blood collection segment held a larger market share; however, the automated segment is expected to experience a higher CAGR during the forecast period. Manual blood collection is the traditional method, where a blood collection needle is used to puncture a venous blood vessel and is connected to a blood collection tube. This method requires skilled professionals, but it carries a risk of injury due to improper needle administration.
Insights on Blood Collection Devices Market by End User
The blood collection devices market is divided into hospitals and pathology laboratories, blood banks, and other sectors. In 2022, hospitals and pathology laboratories represented the largest market segment and are projected to achieve the highest CAGR from 2022 to 2030. These facilities provide healthcare services equipped with specialized scientific instruments, and a trained team is responsible for managing, investigating, and resolving issues related to modern medical science. Medical research teams are continuously working to introduce innovative technologies that enhance treatment methods, laboratory investigations, and other medical activities.
Key sources for this report on the blood collection devices market include the Australian Institute of Health and Welfare, the National Health Commission (NHC), and the International Trade Administration.